Human MnSOD and Cancer Research: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 25: | Line 25: | ||
</StructureSection> | </StructureSection> | ||
== References == | == References == | ||
Azadmanesh, J.; Borgstahl, G.E.O. A Review of the Catalytic Mechanism of Human Manganese Superoxide Dismutase. Antioxidants 2018, 7, 25. | |||
Borgstahl et al. “The structure of a human mitochondrial superoxide dismutase reveals a novel tetrameric interface of two 4-helix bundles.” Cell, Vol. 71, 1 Oct. 2, 1992, 0092-8674(92)90270-M | |||
Church et al. “Increased Manganese Superoxide Dismutase Expression Suppresses the Malignant Phenotype of Human Melanoma Cells.” Pnas.org. | |||
Dhar et al, Sanjit. “UVB-Induced Inactivation of Manganese-Containing Superoxide Dismutase Promotes Mitophagy via ROS-Mediated mTORC2 Pathway Activation.” Jbc.org, 2019, www.jbc.org/content/early/2019/03/11/jbc.RA118.006595.full.pdf. | |||
“Utilizing Superoxide Dismutase Mimetics to Enhance Radiation Therapy Response While Protecting Normal Tissues.” Seminars in Radiation Oncology, W.B. Saunders, 17 Dec. 2018, www.sciencedirect.com/science/article/pii/S1053429618300869. | |||
RCSB Protein Data Bank. “Homepage.” RCSB PDB, www.rcsb.org/. | |||
Turrens, Julio F. “Mitochondrial Formation of Reactive Oxygen Species.” The Journal of Physiology, John Wiley & Sons, Ltd (10.1111), 16 July 2004, physoc.onlinelibrary.wiley.com/doi/full/10.1111/j.1469-7793.2003.00335.x. | |||
Hernández‐López, Reyniel, et al. “Sirtuin 3 Silencing Improves Oxaliplatin Efficacy through Acetylation of MnSOD in Colon Cancer.” Journal of Cellular Physiology, John Wiley & Sons, Ltd, 6 Mar. 2018, onlinelibrary.wiley.com/doi/abs/10.1002/jcp.26443. | |||
Lu, J, et al. “A Small Molecule Activator of SIRT3 Promotes Deacetylation and Activation of Manganese Superoxide Dismutase.” Free Radical Biology & Medicine., U.S. National Library of Medicine, Nov. 2017, www.ncbi.nlm.nih.gov/pubmed/?term=28711502. | |||
